{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:06:20Z","timestamp":1761894380619,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3143,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.bbmt.2006.05.018","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T18:15:54Z","timestamp":1156529754000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin\u2019s Lymphoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Ivan","family":"Aksentijevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Garrett-Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian W.","family":"Flinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.05.018_bib1","first-page":"891","article-title":"Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristine, cyclophosphamide, bleomycin and prednisone)","volume":"7","author":"Bellesi","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bbmt.2006.05.018_bib2","first-page":"996","article-title":"How do patients with aggressive non-Hodgkin\u2019s lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?","volume":"84","author":"Zinzani","year":"1999","journal-title":"Haematologica"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2006.05.018_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/annonc\/5.suppl_2.S91","article-title":"A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermed","volume":"5","author":"Fisher","year":"1994","journal-title":"Ann Oncol"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2006.05.018_bib4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051060","article-title":"Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin\u2019s lymphoma","volume":"40","author":"Fisher","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib5","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.05.018_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.2001.19.2.406","article-title":"Autologous transplantation for diffuse aggressive non-Hodgkin\u2019s lymphoma in patients never achieving remission","volume":"19","author":"Vose","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198706113162402","article-title":"Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma with a poor prognosis","volume":"316","author":"Takvorian","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.05.018_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bmt.1700678","article-title":"Durability of remission after ABMT for NHL","volume":"19","author":"Bolwell","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.05.018_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma","volume":"84","author":"Ratanatharathorn","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.05.018_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1700772","article-title":"Autotransplantation for relapsed or refractory non-Hodgkin\u2019s lymphoma (NHL)","volume":"19","author":"Rapoport","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.05.018_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199504203321601","article-title":"Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin\u2019s lymphoma","volume":"332","author":"Verdonck","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.05.018_bib12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.05.018_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.05.018_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0609.2001.00300.x","article-title":"Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma","volume":"66","author":"Nachbaur","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","article-title":"Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma","volume":"10","author":"Chopra","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1702625","article-title":"Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin\u2019s lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada","volume":"26","author":"Schimmer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.05.018_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/146532402320219745","article-title":"Autologous and allogeneic transplantation for aggressive NHL","volume":"4","author":"Smith","year":"2002","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2006.05.018_bib18","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2006.05.018_bib19","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood.V75.6.1370.1370","article-title":"Bone marrow graft engineering by counterflow centrifugal elutriation","volume":"75","author":"Wagner","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.05.018_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/scd.1.1998.7.151","article-title":"CD34 augmentation improves allogeneic T-cell\u2013depleted bone marrow engraftment","volume":"7","author":"Noga","year":"1998","journal-title":"J Hematother"},{"key":"10.1016\/j.bbmt.2006.05.018_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM198607173150301","article-title":"Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide","volume":"315","author":"Yeager","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.05.018_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1701942","article-title":"Immune modulation in autologous bone marrow transplantation","volume":"24","author":"Vogelsang","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.05.018_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1990.8.3.527","article-title":"High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin\u2019s disease","volume":"8","author":"Jones","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2006.05.018_bib25","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bbmt.2006.05.018_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.bbmt.2006.05.018_bib27","first-page":"279","article-title":"Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL\/TAMO","volume":"14","author":"Conde","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.05.018_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1365-2141.1996.437976.x","article-title":"The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin\u2019s lymphoma","volume":"92","author":"Prince","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2006.05.018_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.1992.10.6.936","article-title":"Treatment of patients with relapsed and resistant non-Hodgkin\u2019s lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation","volume":"10","author":"Gulati","year":"1992","journal-title":"J Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106004046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106004046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:49Z","timestamp":1761056809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106004046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1083879106004046"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.05.018","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin\u2019s Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}